CompletedPhase 3NCT01531179

Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants

Studying Necrotizing enterocolitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Principal Investigator
Mehmet Yekta Oncel, MD
Neonatology
Intervention
Lactobacillus reuteri(drug)
Enrollment
400 target
Eligibility
All sexes
Timeline
20122013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01531179 on ClinicalTrials.gov

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

See all trials for Necrotizing enterocolitis

← Back to all trials